Role of telemedicine in the management of oral anticoagulation in atrial fibrillation: a practical clinical approach

Author:

Barrios Vivencio1ORCID,Cinza-Sanjurjo Sergio2,García-Alegría Javier3ORCID,Freixa-Pamias Román4ORCID,Llordachs-Marques Frederic5,Molina Carlos A6,Santamaría Amparo7ORCID,Vivas David8,Suárez Fernandez Carmen9

Affiliation:

1. Department of Cardiology, Ramón y Cajal University Hospital, Alcalá University, Madrid, Spain.

2. Family Medicine, Porto do Son Health Center, Santiago de Compostela Health Area, A Coruña, Spain

3. Department of Internal Medicine, Costa del Sol Hospital, Marbella (Málaga), Spain

4. Department of Cardiology, Moisés Broggi Hospital, Sant Joan Despí, Barcelona, Spain

5. Expert consultant in E-Health/Telemedicine, Founder at Doctoralia and CEO at Doctomatic, Barcelona, Spain

6. Department of Neurology, Stroke Unit, Vall d’Hebron University Hospital, Barcelona, Spain

7. Department of Hematology, Vinalopó University Hospital, Alicante, Spain

8. Department of Cardiology, San Carlos Hospital, Madrid, Spain

9. Department of Internal Medicine, La Princesa University Hospital, Madrid, Spain

Abstract

Compared with face-to-face consultations, telemedicine has many advantages, including more efficient use of healthcare resources, partial relief of the burden of care, reduced exposure to COVID-19, treatment adjustment, organization of more efficient healthcare circuits and patient empowerment. Ensuring optimal anticoagulation in atrial fibrillation patients is mandatory if we want to reduce the thromboembolic risk. Of note, telemedicine is an excellent option for the long-term management of atrial fibrillation patients. Moreover, direct oral anticoagulants may provide an added value in telemedicine (versus vitamin K antagonists), as it is not necessary to monitor anticoagulant effect or make continuous dosage adjustments. In this multidisciplinary consensus document, the role of telemedicine in anticoagulation of this population is discussed and practical recommendations are provided.

Funder

Bayer Hispania

Publisher

Future Medicine Ltd

Subject

Cardiology and Cardiovascular Medicine,Molecular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3